ECSP23007248A - Implante craneofacial de poliéter éter cetona (PEEK) con depósitos para almacenar y liberar sustancias activas - Google Patents
Implante craneofacial de poliéter éter cetona (PEEK) con depósitos para almacenar y liberar sustancias activasInfo
- Publication number
- ECSP23007248A ECSP23007248A ECSENADI20237248A ECDI202307248A ECSP23007248A EC SP23007248 A ECSP23007248 A EC SP23007248A EC SENADI20237248 A ECSENADI20237248 A EC SENADI20237248A EC DI202307248 A ECDI202307248 A EC DI202307248A EC SP23007248 A ECSP23007248 A EC SP23007248A
- Authority
- EC
- Ecuador
- Prior art keywords
- peek
- reservoirs
- store
- active substances
- ether ketone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2875—Skull or cranium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30252—Three-dimensional shapes quadric-shaped
- A61F2002/30253—Three-dimensional shapes quadric-shaped ellipsoidal or ovoid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30586—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid having two or more inflatable pockets or chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
- A61F2002/3068—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body the pharmaceutical product being in a reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30772—Apertures or holes, e.g. of circular cross section
- A61F2002/30784—Plurality of holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30985—Designing or manufacturing processes using three dimensional printing [3DP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Prostheses (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Abstract
SOLICITUD DE PATENTE VÍA CONVENIO DE PARÍS, consistente en un implante craneofacial compuesto por PEEK para la liberación prolongada y sostenida de al menos un principio activo soluble en un vehículo farmacéuticamente aceptable.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263367226P | 2022-06-29 | 2022-06-29 | |
| CL2022001955 | 2022-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP23007248A true ECSP23007248A (es) | 2024-02-29 |
Family
ID=85172853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI20237248A ECSP23007248A (es) | 2022-06-29 | 2023-01-30 | Implante craneofacial de poliéter éter cetona (PEEK) con depósitos para almacenar y liberar sustancias activas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20240000942A1 (es) |
| JP (1) | JP2024007445A (es) |
| KR (1) | KR20240002678A (es) |
| AR (1) | AR128328A1 (es) |
| AU (1) | AU2023200518A1 (es) |
| BR (1) | BR102023001424A2 (es) |
| CA (1) | CA3187874A1 (es) |
| CH (1) | CH719844A2 (es) |
| CL (1) | CL2023000235A1 (es) |
| CO (1) | CO2023000764A1 (es) |
| DE (1) | DE102023101450A1 (es) |
| EC (1) | ECSP23007248A (es) |
| ES (1) | ES2957984B2 (es) |
| FR (1) | FR3137272A1 (es) |
| IL (1) | IL300184A (es) |
| MX (1) | MX2023000928A (es) |
| NL (1) | NL2034008B1 (es) |
| NO (1) | NO20230450A1 (es) |
| PE (1) | PE20240092A1 (es) |
| UY (1) | UY40117A (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230032649A1 (en) * | 2020-02-24 | 2023-02-02 | Acumed Llc | Craniofacial implants for neuroplastic surgery |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007001624A2 (en) | 2005-06-28 | 2007-01-04 | Microchips, Inc. | Medical and dental implant devices for controlled drug delivery |
| US7824703B2 (en) | 2006-02-01 | 2010-11-02 | Warsaw Orthopedics, Inc. | Medical implants with reservoir(s), and materials preparable from same |
| US7575593B2 (en) * | 2007-01-30 | 2009-08-18 | Medtronic Vascular, Inc. | Implantable device with reservoirs for increased drug loading |
| EP2328511B1 (en) * | 2008-08-29 | 2016-11-02 | SMed - TA/TD LLC | Drug delivery implants |
| WO2011072212A2 (en) | 2009-12-11 | 2011-06-16 | Difusion Technologies, Inc. | Method of manufacturing antimicrobial implants of polyetheretherketone |
| AU2012222860A1 (en) * | 2011-02-28 | 2013-09-26 | Scimotana Pty Ltd | Surgical implant and method |
| AU2015243432A1 (en) * | 2014-04-09 | 2016-11-10 | Matthew ACKERMAN | Implantable bone grafting devices, systems, and methods |
| WO2016205361A1 (en) * | 2015-06-15 | 2016-12-22 | Rowan University | Novel biodegradable and non-biodegradable 3d printed implants as a drug delivery system |
| US10485902B2 (en) | 2015-08-28 | 2019-11-26 | Thomas Jefferson University | Antibiotic drug release sheath |
| AU2016316683B2 (en) * | 2015-09-04 | 2020-07-23 | The Johns Hopkins University | Low-profile intercranial device |
| EP3710079A4 (en) * | 2017-11-14 | 2021-09-01 | Bexson Biomedical, Inc. | SYSTEMS, DEVICES, FORMULATIONS AND PROCEDURES FOR CONTROLLED INGREDIENT DELIVERY |
| US10022233B1 (en) * | 2017-12-04 | 2018-07-17 | Duke University | Orthopedic implant for sustained drug release |
| US11304812B1 (en) * | 2018-02-23 | 2022-04-19 | Syed Khalid | Method of fabricating or modifying an implant |
| CN112638443A (zh) * | 2018-06-29 | 2021-04-09 | 约翰斯·霍普金斯大学 | 兼容磁共振成像的对流增强输送颅骨植入装置及相关方法 |
| AU2020321382B2 (en) * | 2019-08-01 | 2024-08-22 | Theracle, Inc. | Intracranial delivery of medicinal solution |
| WO2021150522A1 (en) * | 2020-01-20 | 2021-07-29 | The Johns Hopkins University | Cranial implant devices and related methods |
| MX2023001826A (es) * | 2020-08-13 | 2023-04-04 | CraniUS LLC | Implantes craneofaciales de alto perfil, específicos de anatomía para reconstrucción combinada de tejido duro y suave con tecnología integrada para suministro de medicina. |
-
2023
- 2023-01-19 MX MX2023000928A patent/MX2023000928A/es unknown
- 2023-01-19 UY UY0001040117A patent/UY40117A/es unknown
- 2023-01-20 CH CH000054/2023A patent/CH719844A2/de unknown
- 2023-01-20 ES ES202330037A patent/ES2957984B2/es active Active
- 2023-01-20 DE DE102023101450.1A patent/DE102023101450A1/de active Pending
- 2023-01-23 NL NL2034008A patent/NL2034008B1/en active
- 2023-01-23 US US18/158,051 patent/US20240000942A1/en active Pending
- 2023-01-23 FR FR2300595A patent/FR3137272A1/fr active Pending
- 2023-01-24 AR ARP230100150A patent/AR128328A1/es unknown
- 2023-01-24 CO CONC2023/0000764A patent/CO2023000764A1/es unknown
- 2023-01-25 IL IL300184A patent/IL300184A/en unknown
- 2023-01-25 CL CL2023000235A patent/CL2023000235A1/es unknown
- 2023-01-25 PE PE2023000138A patent/PE20240092A1/es unknown
- 2023-01-26 BR BR102023001424-0A patent/BR102023001424A2/pt unknown
- 2023-01-27 CA CA3187874A patent/CA3187874A1/en active Pending
- 2023-01-30 EC ECSENADI20237248A patent/ECSP23007248A/es unknown
- 2023-02-01 AU AU2023200518A patent/AU2023200518A1/en not_active Abandoned
- 2023-03-31 KR KR1020230043028A patent/KR20240002678A/ko active Pending
- 2023-04-25 NO NO20230450A patent/NO20230450A1/en unknown
- 2023-06-28 JP JP2023105974A patent/JP2024007445A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL2034008B1 (en) | 2024-01-09 |
| ES2957984B2 (es) | 2024-06-12 |
| FR3137272A1 (fr) | 2024-01-05 |
| CL2023000235A1 (es) | 2023-04-14 |
| AU2023200518A1 (en) | 2024-01-18 |
| KR20240002678A (ko) | 2024-01-05 |
| IL300184A (en) | 2024-01-01 |
| UY40117A (es) | 2023-11-30 |
| CA3187874A1 (en) | 2023-12-29 |
| JP2024007445A (ja) | 2024-01-18 |
| BR102023001424A2 (pt) | 2024-01-09 |
| CO2023000764A1 (es) | 2024-07-29 |
| DE102023101450A1 (de) | 2024-01-04 |
| NO20230450A1 (en) | 2024-01-01 |
| PE20240092A1 (es) | 2024-01-16 |
| ES2957984A1 (es) | 2024-01-30 |
| AR128328A1 (es) | 2024-04-17 |
| MX2023000928A (es) | 2024-01-01 |
| US20240000942A1 (en) | 2024-01-04 |
| CH719844A2 (de) | 2024-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
| AR082579A2 (es) | Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad | |
| AR013117A1 (es) | Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral | |
| AR049009A1 (es) | Gel - crema que contiene ivermectina | |
| UY28431A1 (es) | Peliculas que se disuelven por via oral | |
| PE20040131A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
| ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
| ES2721898T3 (es) | Formulaciones estables para liofilizar partículas terapéuticas | |
| AR048705A1 (es) | Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
| AR032204A1 (es) | Complejos de inclusion de ciclodextrina-drospirenona | |
| AR054300A1 (es) | Aparato y sistema de microproyeccion con escaso potencial infeccioso | |
| ECSP23007248A (es) | Implante craneofacial de poliéter éter cetona (PEEK) con depósitos para almacenar y liberar sustancias activas | |
| CL2008000442A1 (es) | Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades. | |
| PA8586201A1 (es) | Nuevas formulaciones de liberacion prolongada inyectables | |
| CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
| UY38593A (es) | Formulaciones farmacéuticas que contienen peg, un ingrediente activo y un inhibidor de cristalización | |
| AR061047A1 (es) | Comprimido bicapa para la prevencion de los accidentes cardiovasculares, su uso, y metodo para la prevencion de accidentes cardiovasculares | |
| CO2024001992A2 (es) | Composiciones para el tratamiento de la vaginosis bacteriana | |
| UY27275A1 (es) | Composiciones y metodos para aumentar la biodisponibilidad de agentes farmacéuticos | |
| AR031649A1 (es) | Composicion farmaceutica de dronedarona para administracion parenteral | |
| ES2147163B1 (es) | Una composicion farmaceutica con actividad reguladora de la expresion de las moleculas de adhesion. | |
| AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
| PY2303402A (es) | Implante craneofacial de polieter eter cetona (peek) con depositos para almacenar y liberar sustancias activas | |
| AR075866A1 (es) | Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica. | |
| ES2325291A1 (es) | "uso de un extracto de silybum marianum" |